DCode Care Raises Seed Round Co-led By Inflection Point Ventures And PointOne Capital
The funds raised will be utilized for marketing and business development, expansion to cities beyond Bengaluru, and product development to deliver a personalized tech-driven experience for patients
DCode Care announced that it has raised a Seed round co-led by angel investment platform Inflection Point Ventures and PointOne Capital.
The infusion of capital comes six months after the firm raised Pre-Seed financing from early-stage venture firm 100X.VC and a clutch of angel investors.
“Diseases like Cancer are scary. Any survivor would tell you that. But not just emotionally and physically, on the treatment side, this can be a huge drain on patient’s financial resources. DCode Care is currently designing a complete eco-system around cancer care, right from diagnosis to finding the right hospital to financing the treatment. We support them as they look to expand their reach across other critical illnesses. Half the battle is won when you have found the right doctor and the right treatment at the right budget for serious diseases. We believe that DCode Care’s platform has been thoughtfully designed to empower patients with the right information and guidance. The business model has a positive social cause with strong business metrics underneath,” said Ankur Mittal, co-founder, Inflection Point Ventures.
DCode Care helps critical illness patients discover the right treatment and healthcare providers basis their condition and budget. Currently servicing Cancer patients, the startup leverages proprietary technology to bring transparency in medical treatments.
“Having my own family member suffer from cancer, I understand the importance of getting the right counselling on options for treatment, hospitals and care for patients. DCode Care is using the right blend of technology and expert guidance to provide cancer patients and their caregivers the right options and guide them towards the best possible outcomes,” shared Raghavendra Prasad, venture partner, PointOne Capital.
The funds raised will be utilized for marketing and business development, expansion to cities beyond Bengaluru, and product development to deliver a personalized tech-driven experience for patients.
“We are on a mission to empower patients with expert guidance on correct treatment at the right prices. We are pleased to partner with IPV in our vision to create an impact in the space of critical illness management. IPV has opened its wide network of portfolio companies and investor mentors for us. We look forward to leveraging the knowledge pool within the IPV system to grow,” explained Preeti Veenam, founder, DCode Care.
DCode Care has already helped over 50,000 cancer patients. Almost 50 per cent of their patients belong to non-metro cities who are guided to the right clinical treatment options at affordable prices. DCode Care also provides medical financing to its patient base. The company has started with cancer as India has 18 lakh new cancer patients every year. The total spends on cancer care is $ 2.1 billion with over 65 per cent of Indians not having taken insurance. This leads to them struggling to pay for expensive treatments. Through the company’s wide network of partnerships, it can extend tests and treatments at a discounted price, saving up to 30 per cent of overall patient expenses incurred during the treatment. Since the timing of treatment is extremely critical for cancer patients, the earlier they get treatment, the better. With the platform, patients are can start their treatment 50 per cent faster.
"DCode Care fulfills a huge gap in the critical illness journey of a patient. As the first institutional investor, 100X was impressed by the vision of DCode Care as India's first data-driven healthcare discovery platform for critical illness. We firmly believe that the DCode Care has built a good platform which meets a huge societal need and also lends itself to a scalable business model," added Ninad Karpe, partner, 100X.VC.
DCode Care envisions being a comprehensive platform for critical illness patients including cancer, cardiovascular disease, and neurological illnesses.